MR imaging biomarkers in HCC: outcomes correlation in liver transplant listed patients

To determine hepatocellular carcinoma (HCC) magnetic resonance imaging (MRI) biomarkers that enable the prediction of delisting from tumor progression versus successful transplantation in patients listed for orthotopic liver transplantation (OLT).

[1]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[2]  Kathryn J Fowler,et al.  Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. , 2018, Radiology.

[3]  D. Lu,et al.  Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10‐year intention‐to‐treat analysis , 2017, Hepatology.

[4]  H. Tilg,et al.  Indications for liver transplantation in adults , 2016, Wiener klinische Wochenschrift.

[5]  Abhijeet Waghray,et al.  Hepatocellular carcinoma: From diagnosis to treatment. , 2015, World journal of hepatology.

[6]  Jin-Young Choi,et al.  MRI Features of Hepatocellular Carcinoma Related to Biologic Behavior , 2015, Korean journal of radiology.

[7]  T. Fishbein,et al.  Small hepatocellular carcinoma: MRI findings for predicting tumor growth rates. , 2014, Academic radiology.

[8]  M. Ronot,et al.  Hepatocellular carcinoma: diagnostic criteria by imaging techniques. , 2014, Best practice & research. Clinical gastroenterology.

[9]  Jin-Young Choi,et al.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. , 2014, Radiology.

[10]  S. Raman,et al.  Complete tumor encapsulation on magnetic resonance imaging: A potentially useful imaging biomarker for better survival in solitary large hepatocellular carcinoma , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  D. Lu,et al.  MRI detection of intratumoral fat in hepatocellular carcinoma: potential biomarker for a more favorable prognosis. , 2012, AJR. American journal of roentgenology.

[12]  T. Maekita,et al.  Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis , 2011, Hepatology international.

[13]  Y. Maehara,et al.  Both Fibrous Capsule Formation and Extracapsular Penetration Are Powerful Predictors of Poor Survival in Human Hepatocellular Carcinoma: A Histological Assessment of 365 Patients in Japan , 2009, Annals of Surgical Oncology.

[14]  S. Hussain,et al.  MR imaging of hepatocellular carcinoma: Relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns , 2007, Journal of magnetic resonance imaging : JMRI.

[15]  J. Roberts,et al.  Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF‐Expanded Criteria Based on Preoperative Imaging , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  Jae-Joon Chung,et al.  Fat-containing nodules in the cirrhotic liver: chemical shift MRI features and clinical implications. , 2007, AJR. American journal of roentgenology.

[17]  H. Cortez‐Pinto,et al.  Treatment and prognostic factors in patients with hepatocellular carcinoma , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[18]  Sammy Saab,et al.  Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation , 2005, Hepatology.

[19]  Katsuyoshi Ito,et al.  Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions. , 2004, AJR. American journal of roentgenology.

[20]  G. Chau,et al.  Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  D. Mitchell,et al.  MR imaging of hepatocellular carcinoma. , 2002, Magnetic resonance imaging clinics of North America.

[22]  M. Kojiro,et al.  Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. , 2000, Journal of hepatology.

[23]  H. Honda,et al.  Small hepatocellular carcinoma on magnetic resonance imaging. Relation of signal intensity to angiographic and clinicopathologic findings. , 1997, Investigative radiology.

[24]  K. Ohtomo,et al.  Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. , 1993, Radiology.

[25]  S. Fan,et al.  Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases , 1992, Cancer.

[26]  O. Matsui,et al.  Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. , 1992, Radiology.

[27]  N. Moriyama,et al.  Early hepatocellular carcinoma: MR imaging. , 1991, Radiology.

[28]  石神 康生.  Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images : correlation with histopathologic findings , 2011 .

[29]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[30]  A. Chiesa,et al.  The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology , 1999, European Radiology.

[31]  H. Fukuda,et al.  Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. , 1999, Radiology.